DELFI Diagnostics
Biotechnology ResearchMaryland, United States51-200 Employees
DELFI uses artificial intelligence and whole genome sequencing to sensitively detect unique patterns of DNA fragmentation in the blood of patients with cancer.
Insights
Partnerships and Collaborations DELFI Diagnostics has established key partnerships and collaborations with prominent companies like Merck Global Health Innovation Fund and Immunocore Ltd., indicating potential sales opportunities through leveraging these relationships for mutual growth.
Expansion in Healthcare Settings Integration of DELFI Diagnostics' FirstLook Lung test into primary care settings at various locations showcases a growing demand for their blood-based screening tools, creating opportunities for sales expansion in healthcare facilities.
Financial Health and Funding With a revenue ranging between $10M - $50M and funding of $225M, DELFI Diagnostics is financially stable, signaling a strong potential for sales growth and investment in their innovative biotechnology research solutions.
Cancer Monitoring Blood Test Launch The recent launch of a cancer-monitoring blood test by DELFI Diagnostics alongside collaborations with Immunocore opens doors for sales representatives to promote this innovative assay that may improve cancer treatment monitoring, catering to a critical need in the market.
Cutting-Edge Technology Utilization DELFI Diagnostics employs cutting-edge technologies like artificial intelligence and whole genome sequencing, along with a tech stack including Kubernetes, TensorFlow, and Java, providing a unique selling point for sales professionals to position their solutions as industry-leading and technologically advanced.
Similar companies to DELFI Diagnostics
Genomic Health
501
$100M$1BInvitae
1.1K$100M$1BGRAIL
1.4K$100M$1BNatera
3.6K$100M$1BGuardant Health
2.9K$100M$1BMyriad Genetics
2.6K$100M$1BExact Sciences
5.7K$1BFoundation Medicine
1.9K$100M$1BIllumina
9.1K$1B10x Genomics
2.2K$100M$1B
DELFI Diagnostics Tech Stack
DELFI Diagnostics uses 8 technology products and services including Kubernetes, Jamf, Atlassian Jira, and more. Explore DELFI Diagnostics's tech stack below.
- KubernetesContainerization
- JamfEnterprise Mobility Management
- Atlassian JiraIssue Trackers
- TensorFlowMachine Learning
- JavaProgramming Languages
- BambooHRRecruitment Marketing
- reCAPTCHASecurity
- Tailwind CSSUI Frameworks
Media & News
DELFI Diagnostics's Email Address Formats
DELFI Diagnostics uses at least 1 format(s):
| DELFI Diagnostics Email Formats | Percentage |
| Last@delfidiagnostics.com | 69% |
| First.Last@delfidiagnostics.com | 30% |
| Middle@delfidiagnostics.com | 1% |
Frequently Asked Questions
Where is DELFI Diagnostics's headquarters located?
DELFI Diagnostics's main headquarters is located at 2809 Boston St Suite 503 Baltimore, Maryland 21224 US. The company has employees across 5 continents, including North AmericaAfricaSouth America. What is DELFI Diagnostics's official website and social media links?
DELFI Diagnostics's official website is delfidiagnostics.com and has social profiles on LinkedIn.How much revenue does DELFI Diagnostics generate?
As of September 2024, DELFI Diagnostics's annual revenue reached $15M. What is DELFI Diagnostics's SIC code NAICS code?
DELFI Diagnostics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does DELFI Diagnostics have currently?
As of September 2024, DELFI Diagnostics has approximately 192 employees across 5 continents, including North AmericaAfricaSouth America. Key team members include Chief Scientific Officer: N. D.Chief Commercial Officer (cco): J. M.Vice President Of Software Engineering: T. M.. Explore DELFI Diagnostics's employee directory with LeadIQ.What industry does DELFI Diagnostics belong to?
DELFI Diagnostics operates in the Biotechnology Research industry. What technology does DELFI Diagnostics use?
DELFI Diagnostics's tech stack includes KubernetesJamfAtlassian JiraTensorFlowJavaBambooHRreCAPTCHATailwind CSS. What is DELFI Diagnostics's email format?
DELFI Diagnostics's email format typically follows the pattern of . Find more DELFI Diagnostics email formats with LeadIQ. How much funding has DELFI Diagnostics raised to date?
As of September 2024, DELFI Diagnostics has raised $225M in funding. The last funding round occurred on Jul 18, 2022 for $225M.When was DELFI Diagnostics founded?
DELFI Diagnostics was founded in 2019.
Company Overview
- Headquarters
- 2809 Boston St Suite 503 Baltimore, Maryland 21224 US
- Website
- delfidiagnostics.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2019
- Employees
- 51-200
Funding & Financials
- $225M
DELFI Diagnostics has raised a total of $225M of funding over 3 rounds. Their latest funding round was raised on Jul 18, 2022 in the amount of $225M.
- $10M$50M
DELFI Diagnostics's revenue is in the range of $10M$50M
Funding & Financials
- $225M
DELFI Diagnostics has raised a total of $225M of funding over 3 rounds. Their latest funding round was raised on Jul 18, 2022 in the amount of $225M.
- $10M$50M
DELFI Diagnostics's revenue is in the range of $10M$50M
Company Leadership
N. D.Chief Scientific Officer
J. M.Chief Commercial Officer (cco)
T. M.Vice President Of Software Engineering- A. D.Vice President & Head Of People
- C. S.Vice President Finance
Employee Directory
- R. S.Co-Founder And Head Of Data Science
- A. Z.Senior Talent Partner
- J. M.Chief Commercial Officer (cco)
- S. L.People Partner
- T. M.Vice President Of Software Engineering
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
